524654 Share Price Performance
Recent 524654 News & Updates
No updates
Natural Capsules Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 04, 2025
- Earnings per share (EPS)
- 0.60
- Gross Margin
- 47.65%
- Net Profit Margin
- 0.36%
- Debt/Equity Ratio
- 40.4%
Natural Capsules Limited Competitors
About 524654
- Founded
- 1993
- Employees
- 619
- CEO
- WebsiteView website
Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.
Indian Market Performance
- 7 Days: -1.9%
- 3 Months: 5.0%
- 1 Year: -6.4%
- Year to Date: -0.9%
Over the last 7 days, the market has dropped 1.9%, driven by a loss of 2.7% in the Financials sector. As for last year, the market is also down 6.4%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading